Cita APA

Laquente, B., Lopez Martin, J., Richards, D., Illerhaus, G., Chang, D. Z., Kim, G., . . . Calvo, E. (2017). A phase II study to evaluate LY2603618 in combination with gemcitabine in pancreatic cancer patients.

Citación estilo Chicago

Laquente, Berta, et al. A Phase II Study to Evaluate LY2603618 in Combination With Gemcitabine in Pancreatic Cancer Patients. 2017.

Cita MLA

Laquente, Berta, et al. A Phase II Study to Evaluate LY2603618 in Combination With Gemcitabine in Pancreatic Cancer Patients. 2017.